These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 31952546

  • 1. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
    Nie ZY, Yao M, Yang Z, Yang L, Liu XJ, Yu J, Ma Y, Zhang N, Zhang XY, Liu MH, Jiang LL, Luo JM.
    J Exp Clin Cancer Res; 2020 Jan 17; 39(1):17. PubMed ID: 31952546
    [Abstract] [Full Text] [Related]

  • 2. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
    Han Y, Ma Z.
    Anticancer Drugs; 2021 Apr 01; 32(4):427-436. PubMed ID: 33587348
    [Abstract] [Full Text] [Related]

  • 3. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Kaymaz BT, Günel NS, Ceyhan M, Çetintaş VB, Özel B, Yandım MK, Kıpçak S, Aktan Ç, Gökbulut AA, Baran Y, Can BK.
    Tumour Biol; 2015 Sep 01; 36(10):7915-27. PubMed ID: 25953263
    [Abstract] [Full Text] [Related]

  • 4. MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia.
    Liu YY, Jiao WY, Li T, Bao YY.
    Eur Rev Med Pharmacol Sci; 2019 Oct 01; 23(19):8468-8475. PubMed ID: 31646577
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5.
    Jiang X, Cheng Y, Hu C, Zhang A, Ren Y, Xu X.
    Leuk Lymphoma; 2019 Jul 01; 60(7):1709-1720. PubMed ID: 30516071
    [Abstract] [Full Text] [Related]

  • 6. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D, Yang W, Zeng Y, Li W, Wang K, Zhao L, Li J, Ye Y, Guo Q.
    Cell Signal; 2021 Aug 01; 84():110038. PubMed ID: 33984486
    [Abstract] [Full Text] [Related]

  • 7. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
    Farhadi E, Zaker F, Safa M, Rezvani MR.
    Tumour Biol; 2016 Oct 01; 37(10):14117-14128. PubMed ID: 27517565
    [Abstract] [Full Text] [Related]

  • 8. Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia.
    Cao HX, Miao CF, Sang LN, Huang YM, Zhang R, Sun L, Jiang ZX.
    Life Sci; 2020 Feb 15; 243():117255. PubMed ID: 31923418
    [Abstract] [Full Text] [Related]

  • 9. Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p/SENP2/PI3K/AKT/mTOR axis.
    Jiang Y, Xiao S, Huang S, Zhao X, Ding S, Huang Q, Xiao W, Li Z, Zhu H.
    Hematology; 2024 Dec 15; 29(1):2379597. PubMed ID: 39056503
    [Abstract] [Full Text] [Related]

  • 10. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells.
    Chen PH, Liu AJ, Ho KH, Chiu YT, Anne Lin ZH, Lee YT, Shih CM, Chen KC.
    Chem Biol Interact; 2018 Aug 01; 291():144-151. PubMed ID: 29890129
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2.
    Deng Y, Li X, Feng J, Zhang X.
    Biosci Rep; 2018 Jun 29; 38(3):. PubMed ID: 29559564
    [Abstract] [Full Text] [Related]

  • 12. circ_0080145 Enhances Imatinib Resistance of Chronic Myeloid Leukemia by Regulating miR-326/PPFIA1 Axis.
    Che H, Ding H, Jia X.
    Cancer Biother Radiopharm; 2024 Sep 29; 39(7):478-491. PubMed ID: 32598170
    [Abstract] [Full Text] [Related]

  • 13. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
    Cheng Y, Hao Y, Zhang A, Hu C, Jiang X, Wu Q, Xu X.
    Int J Mol Med; 2018 Jan 29; 41(1):455-463. PubMed ID: 29115375
    [Abstract] [Full Text] [Related]

  • 14. Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance.
    Wu YY, Lai HF, Huang TC, Chen YG, Ye RH, Chang PY, Lai SW, Chen YC, Lee CH, Liu WN, Dai MS, Chen JH, Ho CL, Chiu YL.
    Cell Death Dis; 2021 Oct 05; 12(10):908. PubMed ID: 34611140
    [Abstract] [Full Text] [Related]

  • 15. Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells.
    Wang XY, Sun GB, Wang YJ, Yan F.
    Biol Pharm Bull; 2020 Oct 05; 43(10):1526-1533. PubMed ID: 32999163
    [Abstract] [Full Text] [Related]

  • 16. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
    Chen Y, Zhou Q, Zhang L, Zhong Y, Fan G, Zhang Z, Wang R, Jin M, Qiu Y, Kong D.
    Oncotarget; 2017 Apr 25; 8(17):28906-28921. PubMed ID: 28423649
    [Abstract] [Full Text] [Related]

  • 17. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
    Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT.
    Mol Cancer Ther; 2015 Aug 25; 14(8):1777-93. PubMed ID: 26026053
    [Abstract] [Full Text] [Related]

  • 18. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
    Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L.
    Oncotarget; 2017 May 02; 8(18):29679-29698. PubMed ID: 27557509
    [Abstract] [Full Text] [Related]

  • 19. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.
    Casetti L, Martin-Lannerée S, Najjar I, Plo I, Augé S, Roy L, Chomel JC, Lauret E, Turhan AG, Dusanter-Fourt I.
    Cancer Res; 2013 Apr 01; 73(7):2052-8. PubMed ID: 23400594
    [Abstract] [Full Text] [Related]

  • 20. Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
    Waight JD, Banik D, Griffiths EA, Nemeth MJ, Abrams SI.
    J Biol Chem; 2014 May 30; 289(22):15642-52. PubMed ID: 24753251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.